Letters

Merit, Quality, and the SIBR Program

+ See all authors and affiliations

Science  21 Jun 1996:
Vol. 272, Issue 5269, pp. 1725
DOI: 10.1126/science.272.5269.1725a

Summary

Drug companies, hoping to mine biological databases for information that will lead to new products, are buying up experts in genetics and computer science. Competition for people skilled in bioinformatics is so intense that salary offers are being driven sky-high and there is concern that the universities—few of which are training students in the field—are rapidly being depleted of the best researchers.